Article Text

Download PDFPDF

The longer term outcome of children born to mothers with epilepsy
  1. N Adab1,
  2. U Kini2,
  3. J Vinten3,
  4. J Ayres2,
  5. G Baker3,
  6. J Clayton-Smith2,
  7. H Coyle4,
  8. A Fryer5,
  9. J Gorry3,
  10. J Gregg6,
  11. G Mawer4,
  12. P Nicolaides7,
  13. L Pickering8,
  14. L Tunnicliffe8,
  15. D W Chadwick1
  1. 1Department of Neurological Science, The Walton Centre for Neurology and Neurosurgery, Liverpool, UK
  2. 2Department of Clinical Genetics, St Mary’s Hospital, Manchester, UK
  3. 3Department of Neuropsychology, The Walton Centre for Neurology and Neurosurgery, Liverpool
  4. 4Department of Neuroscience, Central Manchester Health Care Trust, Manchester, UK
  5. 5Department of Clinical Genetics, Alder Hey Children’s Hospital NHS Trust, Liverpool, UK
  6. 6Department of Community Paediatrics, Alder Hey Children’s Hospital NHS Trust, Liverpool, UK
  7. 7Department of Paediatric Neurology, Alder Hey Children’s Hospital NHS Trust, Liverpool, UK
  8. 8Clinical Trials Unit, The Walton Centre for Neurology and Neurosurgery, Liverpool
  1. Correspondence to:
 N Adab
 The Walton Centre for Neurology and Neurosurgery, Lower Lane, Fazakerley, Liverpool, L9 7LJ, UK;n.adabvirgin.net

Abstract

Objectives: To determine the prevalence of cognitive delay and possible associated dysmorphic features in children exposed to antiepileptic drugs (AEDs) in utero.

Design: Retrospective study of children born to mothers with epilepsy.

Setting: Regional epilepsy clinics in Liverpool and Manchester, UK.

Participants: Children aged between 6 months and 16 years born to mothers with epilepsy.

Main outcome measures: Structured interviews, hospital records, clinical examination, and psychometric tests (Wechsler) were used to assess exposure and intelligence quotient (IQ). Blinded assessment of photographs was used to score children with characteristic dysmorphic features.

Results: A total of 249 children aged 6 and over were studied: 41 were exposed to sodium valproate, 52 to carbamazepine, 21 to phenytoin, 49 to polytherapy, and 80 were unexposed. Mean verbal IQ was significantly lower in the valproate group compared to unexposed and other monotherapy groups. Multiple regression analysis showed that both valproate exposure and frequent tonic-clonic seizures in pregnancy were significantly associated with a lower verbal IQ despite adjusting for other confounding factors. There was a significant negative correlation between dysmorphic features and verbal IQ in children exposed to valproate.

Conclusions: This study identifies valproate as a drug carrying potential risks for developmental delay and cognitive impairment and is the first to suggest that frequent tonic-clonic seizures have a similar effect. Our results need to be interpreted with caution given their retrospective nature. Women with epilepsy need careful counselling about individual risk benefit of AED treatment before pregnancy.

  • AEDs, antiepileptic drugs
  • AEN, additional educational needs
  • FACS, fetal anticonvulsant syndromes
  • FSIQ, full scale IQ
  • IGE, idiopathic generalised epilepsy
  • IQ, intelligence quotient
  • LD, learning difficulties
  • NART, National Adult Reading Test
  • PIQ, performance IQ
  • SES, socioeconomic status
  • SGSII, Schedule of Growing Skills II
  • VIQ, verbal IQ
  • WISC-III, Wechsler Intelligence Test for Children
  • 95% CI, 95% confidence interval
  • antiepileptic drugs
  • epilepsy
  • pregnancy
View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests: none declared

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles